Loading, please wait ...


News Analytics

4812337 Bayer Logo.
Finerenone (BAY 94-8862) is an investigational, non-steroidal, selective mineralocorticoid receptor antagonist (MRA) that has been shown to reduce many of the harmful effects of mineralocorticoid receptor (MR) overactivation.5 Mineralocorticoid receptor overactivation is a driver of kidney and cardiovascular damage through inflammatory and fibrotic processes.6,7 The Phase III program with finerenone in CKD and T2D randomized 13,000 patients across a broad ...
Google

Subject Matter

  • Healthcare 49.37%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 26.58%
  • Business, economics, society 24.05%
    • Companies, industries, organizations 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions